MoonLake Immunotherapeutics (MLTX)
17.80
-0.20
(-1.11%)
USD |
NASDAQ |
Jun 09, 16:00
17.70
-0.10
(-0.56%)
After-Hours: 07:22
MoonLake Immunotherapeutics SG&A Expense (Quarterly) : 15.51M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 556.75M |
| AC Immune SA | 5.326M |
| CRISPR Therapeutics AG | 17.18M |
| Idorsia Ltd. | 77.58M |
| ADC Therapeutics SA | 22.60M |